NasdaqGM - Nasdaq Real Time Price USD
Tevogen Bio Holdings Inc. (TVGN)
As of 11:23 AM EDT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Expense
35,880.9730
2,273.9700
953.0830
4,618.4620
Operating Income
-35,880.9730
-2,273.9700
-953.0830
-4,618.4620
Net Non Operating Interest Income Expense
177.0730
-256.0310
--
-598.5020
Other Income Expense
90,178.4670
2,462.6760
5,361.4440
-10,379.8340
Pretax Income
54,474.5670
-67.3250
4,408.3610
-15,596.7980
Net Income Common Stockholders
57,918.0790
-67.3250
4,408.3610
-15,596.7980
Diluted NI Available to Com Stockholders
9,748.3740
-67.3250
4,408.3610
-15,596.7980
Basic EPS
0.34
-0.00
0.04
-0.13
Diluted EPS
0.06
-0.00
0.04
-0.13
Basic Average Shares
168,826.4020
165,421.0840
119,999.9890
119,999.9890
Diluted Average Shares
168,826.4020
165,421.0840
119,999.9890
119,999.9890
Total Operating Income as Reported
--
--
-13,724.0640
-4,618.4620
Total Expenses
35,880.9730
2,273.9700
953.0830
4,618.4620
Net Income from Continuing & Discontinued Operation
54,474.5670
-67.3250
4,408.3610
-15,596.7980
Normalized Income
58,616.5970
-2,530.0010
172.8202
-15,596.7980
Interest Expense
--
256.0310
--
598.5020
Net Interest Income
177.0730
-256.0310
--
-598.5020
EBIT
-33,418.2970
188.7060
4,408.3610
-14,998.2960
EBITDA
-33,418.2970
188.7060
4,408.3610
-14,988.9190
Reconciled Depreciation
--
--
230.8230
9.3770
Net Income from Continuing Operation Net Minority Interest
54,474.5670
-67.3250
4,408.3610
-15,596.7980
Total Unusual Items Excluding Goodwill
-5,243.0760
2,462.6760
5,361.4440
--
Total Unusual Items
-5,243.0760
2,462.6760
5,361.4440
--
Normalized EBITDA
-28,175.2210
-2,273.9700
-953.0830
-14,988.9190
Tax Rate for Calcs
0.0002
--
0.0002
--
Tax Effect of Unusual Items
-1,101.0460
--
1,125.9032
--
12/31/2021 - 1/5/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ENSC Ensysce Biosciences, Inc.
0.7191
+24.85%
GNPX Genprex, Inc.
2.3300
+3.54%
THAR Tharimmune, Inc.
3.0700
+7.72%
BIVI BioVie Inc.
2.7100
-1.09%
GRI GRI Bio, Inc.
1.0701
+21.67%
GLYC GlycoMimetics, Inc.
0.4000
-1.70%
GLUE Monte Rosa Therapeutics, Inc.
8.43
-0.88%
DRUG Bright Minds Biosciences Inc.
47.21
+0.88%
ITRM Iterum Therapeutics plc
1.2250
-5.04%
LIXT Lixte Biotechnology Holdings, Inc.
2.0800
-1.42%